Nick Kennedy

45PUBLICATIONS
251CO-AUTHORS
Disease surveillanceMedical mycologyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Jul 17, 2026
Factors associated with preference for in-person versus remote consultations in inflammatory bowel disease in the United Kingdom: secondary analysis of an online survey.

|May 22, 2026
Magnetic resonance imaging-based simplified MaRIA scores are associated with future surgery in Crohn's disease, but modest correlation with ileo-colonoscopic inflammation limits their utility in clinical trials: results from the PROFILE trial.

|Jul 27, 2025
Triaging colorectal urgent referrals in the COVID-19 era using faecal immunochemical testing: a prospective UK real-world multicentre cohort study.

Gareth Walker, Supriya Balasubramanya, Joel Bowen

|Jul 12, 2025
Efficacy and Safety of Infliximab and Vedolizumab Maintenance Therapy in Patients with Crohn's Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis.

Bruce E Sands, Laurent Peyrin-Biroulet, Stefan Schreiber

|Jun 23, 2025
Clinical Utility and Cost-Effectiveness of Pretreatment NUDT15 Pharmacogenetic Testing to Prevent Thiopurine-Induced Myelosuppression: A Genotype-First Reverse Phenotyping Cohort Study Within the UK NIHR Inflammatory Bowel Disease Bioresource.

Christopher Roberts, Jaime Peters, Aleksejs Sazonvos

|Mar 13, 2025
Management of diarrhoea in patients with stable ulcerative colitis with low FODMAP diet, amitriptyline, ondansetron or loperamide: the MODULATE RCT.

Lauren A Moreau, Alexander Charles Ford, Matthew James Brookes

Pageof 8

Frequent Collaborators

20 joint publications

Tariq Ahmad

19 joint publications

James R Goodhand

16 joint publications

Christopher Andrew Lamb

16 joint publications

Neil Chanchlani